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Pneumococcal infections increase each winter, a phe-
nomenon that has not been well explained. We conducted
population-based active surveillance for all cases of inva-
sive pneumococcal disease in seven states; plotted annu-
alized weekly rates by geographic location, age, and lati-
tude; and assessed correlations by time-series analysis. In
all geographic areas, invasive pneumococcal disease
exhibited a distinct winter seasonality, including an
increase among children in the fall preceding that for adults
and a sharp spike in incidence among adults each year
between December 24 and January 7. Pneumococcal dis-
ease correlated inversely with temperature (r –0.82 with a
1-week lag; p<0.0001), but paradoxically the coldest states
had the lowest rates, and no threshold temperature could
be identified. The pattern of disease correlated directly with
the sinusoidal variations in photoperiod (r +0.85 with a 5-
week lag; p<0.0001). Seemingly unrelated seasonal phe-
nomena were also somewhat correlated. The reproducible
seasonal patterns in varied geographic locations are con-
sistent with the hypothesis that nationwide seasonal
changes such as photoperiod-dependent variation in host
susceptibility may underlie pneumococcal seasonality, but
caution is indicated in assigning causality as a result of
such correlations.
A
s with many infectious diseases, the incidence of
invasive pneumococcal infection rises and falls in an
annual seasonal pattern that has been repeatedly docu-
mented but never well explained. The winter increase in
cases has been attributed to cold weather, lower humidity,
the crowding together of susceptible hosts, associated viral
infections, and air pollution (1–3). Explanations for the
cause of pneumococcal seasonality often appear contradic-
tory. Atemporary increase in the incidence of invasive dis-
ease was associated with two severe winters in the
Netherlands (4), but in Alaska, the number of invasive
cases is highest in summer months (5). The seasonal vari-
ation has been more apparent in adult invasive pneumo-
coccal disease than in pediatric cases (1), although some
seasonal variation in acquisition of nasopharyngeal colo-
nization also has been documented in children (6). These
disparate observations have been difficult to reconcile with
a unifying explanation for pneumococcal seasonality.
Arecent hypothesis proposes that the seasonal variation
in the incidence of some infectious diseases is attributable
to seasonal variation in host physiology, such as the densi-
ty of a cellular receptor or the activity of the immune
response (7). Many mammals exhibit distinct physiologic
changes with the changing seasons, typically timed to the
light-dark cycle and mediated by melatonin (humans
exhibit some such changes) (8–11). Experiments with mice
provide some evidence that susceptibility to fatal pneumo-
coccal disease varies with the animal’s innate circadian
rhythm (12–14). Determining the relevance, if any, of
these observations to human pneumococcal infections
would be advanced by a detailed description of the season-
al patterns of pneumococcal infections of various age
groups and different geographic areas with distinct weath-
er patterns. We evaluated data from a population-based
surveillance system in seven geographic areas in the
United States (Active Bacterial Core Surveillance) to
describe the seasonal variation in invasive pneumococcal
disease and explore these hypotheses.
Methods
Surveillance for invasive pneumococcal disease was
performed from January 1, 1996, through December 31,
1998, in the counties of seven U.S. states, as consistently
defined in the Active Bacterial Core Surveillance of the
Emerging Infections Program Network. Geographic loca-
tion was grouped by state and by latitude (Figure 1),
including eight counties in Georgia and five counties in
Tennessee (latitude 33°–35° north; defined here as south-
ern sites), one county in California and six counties in
Maryland (latitude 37°–39° north; middle sites), and the
entire state of Connecticut, seven counties in Minnesota,
and three counties in Oregon (latitude 41°–45° north;
northern sites). Invasive disease caused by group A strep-
tococci and group B streptococci was also assessed for
comparison with pneumococcal disease.
Invasive disease was defined as disease in which an
organism had been isolated from a normally sterile site
(such as blood or cerebrospinal fluid) in a resident of the
surveillance area. Each case was considered to have
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veillance area, project personnel communicated regularly
with contacts in all microbiology laboratories serving
acute-care hospitals and completed standardized case-
report forms. Audits were performed at least every 6
months to evaluate reporting sensitivity and identify unre-
ported cases. All isolates were sent to the Centers for
Disease Control and Prevention or the University of Texas
Health Science Center at San Antonio on blood agar slants
and confirmed as pneumococci on the basis of optochin
susceptibility and bile solubility.
Daily surface weather data were obtained from weather
stations in each surveillance site (Atlanta, Memphis, San
Francisco, Baltimore, Hartford, Minneapolis, and
Portland) from the National Climate Disease Center,
Asheville, North Carolina (available from: URL:
http://www.ncdc.noaa.gov). Sunrise and sunset times for
each surveillance week were obtained for each of the
above seven sites from the U.S. Naval Observatory,
Washington, D.C. (available from: URL: http:// aa.usno.
navy.mil). Monthly figures for electric utility gas con-
sumption were obtained from the Energy Information
Administration, Washington, D.C. (available from: URL:
http://www.eia. doe.gov), and figures for public construc-
tion expenditures were obtained from the U.S. Census
Bureau, Washington, D.C. (available from: URL:
http://www.census.gov).
Weekly numbers of cases were converted to annualized
rates by dividing by the census population in the relevant
counties for the appropriate surveillance year and multi-
plying by 100,000 population and 52 weeks (to get cases
per 100,000 population per year). We then plotted annual-
ized rates by state, latitude group (as categorized above),
and age (adults >18 years and children). 
Time series analysis was performed with SAS software
(version 8.2, SAS Institute, Inc., Cary, NC) and Epi Info
software version 6.02 (Centers for Disease Control and
Prevention, Atlanta, GA). Annualized weekly rate correla-
tions with mean weekly temperature (in degrees F), total
weekly precipitation (100ths of inches), and mean weekly
minutes of darkness were calculated as Pearson correlation
coefficients with time lags ranging from 0 to 8 weeks.
Time lags were limited to an 8-week range because the
highest correlations from exploratory analysis in the annu-
alized weekly rate with the climatic data occurred within 2
months. Correlations with monthly gas consumption and
construction expenditures were explored with time lags of
20 to 36 months because the data were available from 1999
to 2001, whereas the weekly pneumococcal disease rates
were available from 1996 to 1998. Weather data were
missing from Atlanta for 1996 and were not included;
occasional missing readings were otherwise replaced by
interpolation. 
Results
Over the 3-year period, 11,614 cases of invasive pneu-
mococcal disease were identified among the approximate-
ly 15,221,605 residents of the surveillance areas. The
annualized weekly rate of invasive pneumococcal disease
was distinctly seasonal, varying from approximately 10
cases per 100,000 population during the summer to
approximately 35 cases per 100,000 during the winter
(Figure 2). No seasonal variation was seen in the incidence
of group B streptococcal infection, and a mild spring peak
was seen in group A streptococcal infection. A prominent
spike in the rate of invasive pneumococcal disease to
50–75 cases per 100,000 occurred during the last week of
December and the first week of January in each of the sur-
veillance years.
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Figure 1. Map of the continental United States showing the approx-
imate locations of the seven surveillance sites, grouped for some
analyses as southern sites (illustrated in red), middle sites (green),
and northern sites (blue).
Figure 2. Weekly rates of invasive pneumococcal disease in the
United States, January 1996–December 1998. Weekly numbers of
cases from active surveillance areas in California, Connecticut,
Georgia, Maryland, Minnesota, Oregon, and Tennessee were
divided by the population under surveillance that year and multi-
plied by 52 to give annualized weekly rates. The seasonal patterns were similar when the data from
each state were plotted separately and when the states were
grouped into the three latitude groups (Figure 3). The num-
ber of weekly cases increased approximately fourfold from
summer to winter, and a prominent spike in the number of
weekly cases occurred during the last week of December
and the first week of January.
The pattern of seasonal variation was somewhat differ-
ent in children compared to adults (Figure 4). The annual
rise in incidence among children preceded that of adults,
reaching the highest incidence during September and
maintaining a high incidence throughout the fall. The spike
in incidence during the last week of each year and first
week of the subsequent year was seen in adults but not in
children.
We further explored the characteristics of persons with
invasive pneumococcal disease during the prominent
annual spike (defined as December 20–January 10 of each
year) and those experiencing invasive disease during the
surrounding weeks (December 1–19, and January 11–31).
Patients with invasive disease occurring during the spike
and nonspike periods had similar demographic character-
istics, except that adults were disproportionately repre-
sented during the spike (Table). After children were
excluded, the median age of adults with invasive disease
during the spike was 60 years, compared with 56 years for
adults in the surrounding weeks (p=0.05). No similar
spike in incidence occurred for either group A or group B
streptococcal disease.
The seasonal peaks in invasive pneumococcal disease
in each of the three latitude groups correlated with increas-
es in the number of hours of darkness and with cold tem-
peratures in the winter, but correlation was poor with sea-
sonal variations in total precipitation (Figure 3).
Correlations were highly significant (Pearson’s correlation
coefficients all < –0.5; p<0.0001) for pneumococcal dis-
ease and temperature, with time lags ranging from 0 to 8
weeks (highest r –0.82 with a 1-week lag). Correlations
were also highly significant (r all >0.7; p<0.0001) for min-
utes of darkness and pneumococcal disease (highest r
+0.85 with a 5-week lag). Temperature and photoperiod
were themselves highly correlated with each other (r
–0.95; p<0.0001). Precipitation did not correlate well with
pneumococcal disease (r all <0.3, with best correlation of
0.29 using a 0-week lag). 
The temperature curves for the individual states showed
distinct patterns (data not shown), as did the temperature
curves when sites were grouped by latitude (Figure 3c), but
these variations were not associated with site-specific vari-
ation in pneumococcal disease. For example, the northern
sites, with temperatures averaging 10°–20° lower than the
southern sites throughout the year, did not have higher rates
of invasive pneumococcal disease (Figure 3a). No evi-
Emerging Infectious Diseases • Vol. 9, No. 5, May 2003 575
RESEARCH
Figure 3. The relationship of invasive pneumococcal disease to
photoperiod, temperature, and precipitation in three surveillance
areas, grouped by latitude, 1996–1998. Southern surveillance
areas were in Georgia and Tennessee (red lines; 33°–35° north
latitude), middle areas were in California and Maryland (green
lines; 37°–39° north latitude), and northern areas were in
Connecticut, Minnesota, and Oregon (blue lines; 41°–45° north lat-
itude). a: Rates of invasive pneumococcal disease; b: hours of
darkness calculated for the 15th day of each month; c: mean
monthly surface air temperature recorded at weather stations in
each of the seven surveillance sites. d: total monthly precipitation
recorded at weather stations in each of the seven surveillance
sites. Pneumococcal disease correlated directly with photoperiod
(r 0.85 with a 5-week lag; p<0.0001), indirectly with temperature (r
–0.82 with a 1-week lag; p<0.0001), and poorly with precipitation
(r 0 to <0.3). dence of a longer pneumococcal season in northern sites
than in southern sites was evident, a finding that might
have been expected if a threshold temperature existed,
below which pneumococcal disease rates increase.
Seasonal variations in photoperiod, or the length of the
light-dark period, also corresponded with the seasonal
variation in pneumococcal disease. Photoperiod was a sea-
sonally varying phenomenon with less site-to-site varia-
tion than temperature (Figure 3b), similar to the consistent
pattern of pneumococcal disease rates across the sites. The
variation in the magnitude of the photoperiod curves was
slightly more pronounced for northern sites than for south-
ern sites (Figure 3b), a pattern which was not seen in inva-
sive pneumococcal disease (Figure 3a). Associations
between the seasonal increases in invasive pneumococcal
disease and seemingly unrelated phenomena were not dif-
ficult to demonstrate, such as the correlations with season-
al variation in public construction expenditures (r –0.84
with a 35-month lag) and electric utility gas consumption
(r –0.92 with a 22-month lag) (Figure 5).
Discussion
A distinctive and regular seasonal variation in the inci-
dence of invasive pneumococcal disease was confirmed by
this analysis, as has been reported by others (1,3,15–17).
We found that the patterns of seasonal variation were
remarkably consistent across our seven geographically dis-
tinct surveillance areas, and we used the site-specific dif-
ferences in weather across these areas to evaluate proposed
explanations for the cause of pneumococcal seasonality.
The unique seasonal patterns in children’s infections  as
compared to those of adults, and the peculiar spike in inci-
dence in adults during the same 1- to 2-week period each
year remain incompletely explained, although these obser-
vations should provide ample opportunities for testing
hypotheses in future studies.
The shapes of the invasive pneumococcal disease
curves were remarkably consistent across all seven sur-
veillance sites, including the timing of the summertime
nadir, the fall upswing in incidence, and the midwinter
peak. These patterns were consistent despite marked dif-
ferences in rainfall patterns and, to a lesser extent, differ-
ences in air temperature across these geographically wide-
spread sites. If colder temperature is what drives the win-
ter increase in pneumococcal disease, we might have
expected higher rates throughout the year from northern
sites, but that is not what we found. Alternatively, pneumo-
coccal disease might increase when temperatures drop
below some biologic threshold. Such biologic thresholds
are present in certain temperature-sensitive viruses, for
example, that are useful as vaccines because they are not
viable in the warmer temperatures of the human lung (18).
Such a temperature threshold for pneumococcal disease
might be expected to result in a longer “pneumococcal sea-
son” in northern sites, a pattern we also did not find.
Temperature and photoperiod variations need to be
investigated further with datasets obtained by using simi-
lar methods from regions with wider latitude and tempera-
ture variations than we used here. Preliminary review of a
smaller dataset of invasive pneumococcal disease from a
different surveillance system in Alaska did not identify ele-
vated rates of pneumococcal disease associated with the
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Figure 4. Weekly rates of invasive pneumococcal disease in chil-
dren (dotted line; ages 0–17 years), and adults (solid line; age >18
years) in the United States, 1996–1998. Weekly numbers of cases
from seven active surveillance areas were divided by the age-spe-
cific population and multiplied by 52 to give annualized weekly
rates. 
Table. Characteristics of persons with invasive pneumococcal 
disease during an annual winter spike in incidence compared 
with those experiencing invasive pneumococcal disease during 
the surrounding weeks, 1996–1998
a 
% of patients  
with characteristic 
Characteristic 
Nonspike 
(N=1,647) 
Spike 
(N=1,351)  p value
b 
Sex (% male)  54.9  51.4  0.07 
Race (% white)  56.6  60.8  0.07 
Age (% adult)  74.3  81.7  0.0000013 
Survival  87.1  87.5  0.92 
State      0.49 
   California  6.0  4.9  – 
   Connecticut  17.7  18.9  – 
   Georgia  25.6  25.3  – 
   Maryland  20.2  19.1  – 
   Minnesota  10.4  11.3  – 
   Oregon  6.8  5.8  – 
   Tennessee  13.3  14.7  – 
Syndrome      0.24 
   Bacteremia  35.6  33.0  – 
   Pneumonia  56.4  59.6  – 
   Meningitis  4.9  4.6  – 
aThe spike period was defined as December 20–January 10 of each year, and the 
nonspike periods were December 1–19 and January 11–31. 
bp value calculated by chi-square test of the 2 x N table, with Yates correction. colder weather and longer winter and also did not display
the consistent seasonal variations seen in our continental
U.S. sites (J. Butler, pers. comm.).
Some of the apparent variation in incidence of invasive
pneumococcal disease seen in different studies may be
attributable to variations in blood-culturing patterns
(19,20). Geographic variation in blood culture practices
may be more likely to influence the size of seasonal peaks
and less likely to affect their timing, as we observed.
Strengths of this analysis include the large population
under surveillance and the consistent methods used to
identify cases across all seven geographically distinct sur-
veillance areas; these factors should tend to minimize any
effects of local differences in blood-culturing practices or
institutional variation in case ascertainment.
The similar seasonal patterns observed in our seven sur-
veillance sites, despite their wide variations in air temper-
ature, precipitation, and other weather patterns, argue that
the signal guiding pneumococcal seasonal variations is one
that is more consistently present in all sites. Photoperiod
has been shown to be the most pervasive signal for season-
al changes in biologic systems (10,21–23), and we believe
our findings are consistent with the proposal that photope-
riod also contributes to the seasonality of invasive pneu-
mococcal disease in humans. The sinusoidal variation in
photoperiod across the sites correlated closely with the pat-
tern of invasive pneumococcal disease. We did not find a
greater magnitude of pneumococcal variation from north-
ern sites, and definitively identifying photoperiod, rather
than temperature, as the driving phenomenon was not pos-
sible from this dataset. Because temperature and photope-
riod are themselves highly correlated, evaluating the rela-
tive contributions of each to invasive pneumococcal dis-
ease will likely require further exploration with more years
of data from more geographically diverse sites.
We emphasize that correlating seasonal variations in
invasive pneumococcal disease with temperature and pho-
toperiod provides insufficient evidence to establish a
causal link. Using brief searches of the Internet, we readi-
ly identified seasonal variations in housing construction,
gas consumption, and other seemingly unrelated phenom-
ena that were also significantly correlated with the season-
al variation in pneumococcal disease. Because so many
phenomena vary seasonally, evaluating one or two hypoth-
esized causes for seasonal variation in disease and con-
cluding that the close correlation supports causality is a
pitfall all investigators in this field must take care to avoid.
Accumulating evidence is supporting the biologic plau-
sibility that preceding respiratory virus infections, influen-
za in particular, increase susceptibility to invasive pneu-
mococcal disease (24,25). We did not have comparable
data on virologically confirmed influenza infections from
each of the seven surveillance sites to include in this analy-
sis, but such information should be sought in future evalu-
ations.
Some experimental evidence exists to support the con-
cept that cyclical variation in susceptibility to pneumococ-
cal infections is present in the mammalian host, and that
the light-dark cycle provides the signal that entrains this
cyclical pattern. Mice kept in windowless rooms with a
controlled light-dark cycle are less susceptible to pneumo-
coccal infection during the dark phase (12). When such
mice were inoculated intraperitoneally with virulent pneu-
mococci during the dark phase (0400), there was a slower
increase in bacteremia (13), and the mice survived signifi-
cantly longer, compared to those challenged during the
light phase (12). In blinded mice, this pattern of decreased
susceptibility was maintained on an approximately 24-
hour (circadian) pattern but cycled out of phase with the
room lighting. These findings indicate the presence of an
endogenous rhythm of susceptibility to pneumococcal
infection that is normally entrained to a strict 24-hour pat-
tern by visual detection of the daily light-dark cycle (14).
Whether this circadian variation in susceptibility is accom-
panied by seasonal variation has not been evaluated,
although the two periodic phenomena are closely related in
most biologic systems (23). Humans retain the physiolog-
ic capacity to respond to changes in photoperiod (11,
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Figure 5. Seasonal variations in U.S. electric utility gas consump-
tion (a) and public construction expenditures (b). Both parameters
correlated indirectly with the invasive pneumococcal disease rates
(gas consumption: r –0.92 with a 22-month lag; and construction:
r –0.84 with a 35-month lag). Data were obtained from the Energy
Information Administration and the U.S. Census Bureau, respec-
tively. 
a
b26–28), but some evidence exists that artificial lighting
blunts these responses (29). Moreover, the degree to which
seasonal changes in light cycles influences human physiol-
ogy, if at all, is not clear.
The seasonal pattern in children was distinct from that
in adults, consistent with differences in clinical disease in
children and with the observations of others (1,5,30,31).
Children are the reservoirs for pneumococci in the commu-
nity, with nasopharyngeal colonization varying slightly
(6), if at all (32), throughout the year. We observed a sea-
sonal peak in children that was broader and flatter than that
in adults, with an early autumn rise to the peak and an
absence of the midwinter spike. Others have described this
as a biphasic pattern, with a flattening or drop in incidence
in midwinter (30,31,33,34); we did not observe this pat-
tern. We speculate that the early autumn rise may be asso-
ciated with the return to school and exchange of new
serotypes, which may then be transmitted to adult contacts.
The substantial variation in invasive disease despite fairly
steady carriage supports a role for increasing host suscep-
tibility or other predisposing factors, rather than appear-
ance and disappearance of the pathogen, as an underlying
explanation.
The prominent midwinter spike in incidence we
observed does not appear to be an artifact of the surveil-
lance system. The spike, present in all seven states, was not
seen for group A or group B streptococcal disease, which
were reported through the same system. Persons with inva-
sive disease during the spike were significantly older but
otherwise demographically similar to those with invasive
disease during the surrounding weeks. The consistent tim-
ing of the spike during the weeks of December 24–
January 7 is provocative. This is a time when many U.S.
families gather for Christmas and New Year’s holidays,
perhaps providing an opportunity for exposure of older rel-
atives to new serotypes from young children at a time
when their annual susceptibility to pneumococcal disease
is at its peak. Previous studies have documented an associ-
ation between exposure to young children and invasive
pneumococcal disease (35,36). Others have not reported
such a spike, but most such analyses have grouped the data
by month, an approach that would have led us to miss the
spike in our data. 
We encourage others with similar databases to examine
their data by weekly intervals, to distinguish patterns in
adults from those in children, and to report information on
latitude, temperature patterns, humidity, and other vari-
ables to allow for a consistent exploration of the influences
on pneumococcal seasonality. Variation in susceptibility in
the human host is one hypothesis that should be routinely
considered.
Dr. Dowell is the director of the International Emerging
Infections Program in Thailand, the first of a planned network of
such collaborations between the Centers for Disease Control and
Prevention and host country ministries of health. His research
interests include the seasonality of infectious diseases and the
detection and control of emerging infections.
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